Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

MaxQ Medical

Request full access

Automated ultrasound imaging and HIFU therapy system.

Sunnyvale, United StatesFounded 2023Health Tech & Medtech

About MaxQ Medical

MaxQ Medical, Inc. is a health-tech company based in Sunnyvale, California, operating in the urology sector. The firm is the first spinout from Orchard Ultrasound Innovation, an incubator that commercializes breakthrough ultrasound technology developed at Stanford University by Professor Pierre Khuri-Yakub, inventor of the Capacitive Micromachined Ultrasonic Transducer (CMUT). This foundation in decades of semiconductor ultrasound research provides a significant scientific basis for its technology platform. Led by CEO Amir Tehrani and Executive Chairman Amir Abolfathi, the company is developing a next-generation platform for prostate care. In August 2026, MaxQ Medical announced the closing of a $31.5 million Series A financing round. The round was led by prominent investors including Atlantic Blue Ventures, S3 Ventures, and Olympus Innovation Ventures, the venture arm of global endoscopy player Olympus. The capital is allocated to expanding the team and advancing the company's ongoing clinical programs. The company’s core product is an all-in-one, transurethral system that combines advanced ultrasound imaging with targeted High-Intensity Focused Ultrasound (HIFU) therapy. This platform is designed to be a fully automated, outpatient procedure that gives urologists direct visibility inside the prostate and the ability to treat the targeted tissue in a single session. A key design feature is its urethra-preserving capability, which aims to minimize common side effects associated with traditional treatments, such as injury, bleeding, and impact on sexual function. MaxQ Medical's strategy is to offer a solution that provides the durability of gold-standard resective therapies while maintaining a side-effect profile comparable to less invasive techniques. The initial target market is the treatment of benign prostatic hyperplasia (BPH), a condition affecting an estimated 40 million men in the U.S. The company has long-term plans to expand its platform's application to include focal therapy for prostate cancer and broader diagnostics like biopsies and tumor mapping. The MaxQ system is currently investigational and is not yet available for commercial use in the United States.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2023
Headquarters
Sunnyvale, United States
Open positions
None listed
Dealroom signal
20.7/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Radiology, Medical Imaging, Non-Invasive medical devices and treatments
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Aug 2026 $32M $126M Olympus Innovation Ventures · Highside Capital Management · S3 Ventures ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

MaxQ Medical in the Sunnyvale ecosystem

Live from Dealroom

The MaxQ Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Olympus Innovation Ventures
  • S3 Ventures
  • Highside Capital Management
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about MaxQ Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MaxQ Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.